Cargando…

Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates

Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arawaka, Shigeki, Sato, Hiroyasu, Sasaki, Asuka, Koyama, Shingo, Kato, Takeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472914/
https://www.ncbi.nlm.nih.gov/pubmed/28619113
http://dx.doi.org/10.1186/s40478-017-0452-6
_version_ 1783244205385056256
author Arawaka, Shigeki
Sato, Hiroyasu
Sasaki, Asuka
Koyama, Shingo
Kato, Takeo
author_facet Arawaka, Shigeki
Sato, Hiroyasu
Sasaki, Asuka
Koyama, Shingo
Kato, Takeo
author_sort Arawaka, Shigeki
collection PubMed
description Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated at Ser129 in brains with normal individuals. It is unclear why extensive phosphorylation occurs in the pathological process of PD. To address this issue, we investigated a mechanism and role of Ser129-phosphorylation in regulating accumulation of α-synuclein. In CHO cells, the levels of Ser129-phosphorylated soluble α-synuclein were maintained constantly to those of total α-synuclein in intracellular and extracellular spaces. In SH-SY5Y cells and rat primary cortical neurons, mitochondrial impairment by rotenone or MPP(+) enhanced Ser129-phosphorylation through increased influx of extracellular Ca(2+). This elevation was suppressively controlled by targeting Ser129-phosphorylated α-synuclein to the proteasome pathway. Rotenone-induced insoluble α-synuclein was also targeted by Ser129-phosphoryation to the proteasome pathway. Experiments with epoxomicin and chloroquine showed that proteasomal targeting of insoluble Ser129-phosphorylated α-synuclein was enhanced under lysosome inhibition and it reduced accumulation of insoluble total α-synuclein. However, in a rat AAV-mediated α-synuclein overexpression model, there was no difference in the number of total α-synuclein aggregates between A53T mutant and A53T plus S129A double mutant α-synuclein, although Ser129-phosphorylated α-synuclein-positive aggregates were increased in rats expressing A53T α-synuclein. These findings suggest that Ser129-phosphorylation occurs against stress conditions, which increases influx of extracellular Ca(2+), and it prevents accumulation of insoluble α-synuclein by evoking proteasomal clearance complementary to lysosomal one. However, Ser129-phosphorylation may provide an ineffective signal for degradation-resistant aggregates, causing extensive phosphorylation in aggregates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0452-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5472914
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54729142017-06-21 Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates Arawaka, Shigeki Sato, Hiroyasu Sasaki, Asuka Koyama, Shingo Kato, Takeo Acta Neuropathol Commun Research Parkinson’s disease (PD) is characterized neuropathologically by intracellular aggregates of fibrillar α-synuclein, termed Lewy bodies (LBs). Approximately 90% of α-synuclein deposited as LBs is phosphorylated at Ser129 in brains with PD. In contrast, only 4% of total α-synuclein is phosphorylated at Ser129 in brains with normal individuals. It is unclear why extensive phosphorylation occurs in the pathological process of PD. To address this issue, we investigated a mechanism and role of Ser129-phosphorylation in regulating accumulation of α-synuclein. In CHO cells, the levels of Ser129-phosphorylated soluble α-synuclein were maintained constantly to those of total α-synuclein in intracellular and extracellular spaces. In SH-SY5Y cells and rat primary cortical neurons, mitochondrial impairment by rotenone or MPP(+) enhanced Ser129-phosphorylation through increased influx of extracellular Ca(2+). This elevation was suppressively controlled by targeting Ser129-phosphorylated α-synuclein to the proteasome pathway. Rotenone-induced insoluble α-synuclein was also targeted by Ser129-phosphoryation to the proteasome pathway. Experiments with epoxomicin and chloroquine showed that proteasomal targeting of insoluble Ser129-phosphorylated α-synuclein was enhanced under lysosome inhibition and it reduced accumulation of insoluble total α-synuclein. However, in a rat AAV-mediated α-synuclein overexpression model, there was no difference in the number of total α-synuclein aggregates between A53T mutant and A53T plus S129A double mutant α-synuclein, although Ser129-phosphorylated α-synuclein-positive aggregates were increased in rats expressing A53T α-synuclein. These findings suggest that Ser129-phosphorylation occurs against stress conditions, which increases influx of extracellular Ca(2+), and it prevents accumulation of insoluble α-synuclein by evoking proteasomal clearance complementary to lysosomal one. However, Ser129-phosphorylation may provide an ineffective signal for degradation-resistant aggregates, causing extensive phosphorylation in aggregates. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-017-0452-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-15 /pmc/articles/PMC5472914/ /pubmed/28619113 http://dx.doi.org/10.1186/s40478-017-0452-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Arawaka, Shigeki
Sato, Hiroyasu
Sasaki, Asuka
Koyama, Shingo
Kato, Takeo
Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title_full Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title_fullStr Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title_full_unstemmed Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title_short Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
title_sort mechanisms underlying extensive ser129-phosphorylation in α-synuclein aggregates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472914/
https://www.ncbi.nlm.nih.gov/pubmed/28619113
http://dx.doi.org/10.1186/s40478-017-0452-6
work_keys_str_mv AT arawakashigeki mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates
AT satohiroyasu mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates
AT sasakiasuka mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates
AT koyamashingo mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates
AT katotakeo mechanismsunderlyingextensiveser129phosphorylationinasynucleinaggregates